AI news impact · China A-shares

Bide Pharmatech Co. Ltd. Class A (688073) news impact

On 2026-11-09 Wave Radar's AI rated the news on Bide Pharmatech Co. Ltd. Class A as neutral (impact score +5%).

Bide Pharmatech appeared only in automated ranking tables of STAR Market margin balance increments, without standalone disclosures.

Direction
Neutral
Impact score
+5%
Confidence
40%
Headlines read
5
Date
2026-11-09
Open 688073 news in Wave Radar

AI assessment

Regular listing in margin trading tracking tables without new corporate, financial, or strategic disclosures, indicating neutral impact.

Sector impact

Neutral impact with negligible influence on the pharmaceutical building blocks sector.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Bide Pharmatech Co. Ltd. Class A

688073 valuation

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.